DE69923587D1 - Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden - Google Patents
Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethodenInfo
- Publication number
- DE69923587D1 DE69923587D1 DE69923587T DE69923587T DE69923587D1 DE 69923587 D1 DE69923587 D1 DE 69923587D1 DE 69923587 T DE69923587 T DE 69923587T DE 69923587 T DE69923587 T DE 69923587T DE 69923587 D1 DE69923587 D1 DE 69923587D1
- Authority
- DE
- Germany
- Prior art keywords
- glp
- receptor
- peptide
- antagonists
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000007446 Glucagon-Like Peptide-1 Receptor Human genes 0.000 title abstract 5
- 108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000004913 activation Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 abstract 1
- 101710176384 Peptide 1 Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000003629 gastrointestinal hormone Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical compound N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11173698P | 1998-12-10 | 1998-12-10 | |
| US111736P | 1998-12-10 | ||
| PCT/US1999/029065 WO2000033839A1 (en) | 1998-12-10 | 1999-12-08 | Non-peptide antagonists of glp-1 receptor and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69923587D1 true DE69923587D1 (de) | 2005-03-10 |
| DE69923587T2 DE69923587T2 (de) | 2005-06-23 |
Family
ID=22340176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69923587T Expired - Fee Related DE69923587T2 (de) | 1998-12-10 | 1999-12-08 | Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6469021B1 (de) |
| EP (1) | EP1137413B1 (de) |
| JP (1) | JP2002531501A (de) |
| KR (1) | KR20010089563A (de) |
| AT (1) | ATE288268T1 (de) |
| AU (1) | AU758968B2 (de) |
| BR (1) | BR9916965A (de) |
| CA (1) | CA2350887A1 (de) |
| DE (1) | DE69923587T2 (de) |
| ES (1) | ES2233089T3 (de) |
| NZ (1) | NZ511698A (de) |
| PT (1) | PT1137413E (de) |
| WO (1) | WO2000033839A1 (de) |
| ZA (1) | ZA200104128B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003532691A (ja) | 2000-05-05 | 2003-11-05 | ノボ ノルディスク アクティーゼルスカブ | 重症疾患神経障害 |
| WO2002045712A1 (en) * | 2000-12-04 | 2002-06-13 | Biovitrum Ab | Novel method and use |
| US20030199445A1 (en) | 2002-02-07 | 2003-10-23 | Knudsen Lotte Bjerre | Use of GLP-1 compound for treatment of critically ill patients |
| AU2003203146A1 (en) * | 2002-02-07 | 2003-09-02 | Novo Nordisk A/S | Use of glp-1 compound for treatment of critically ill patients |
| MXPA04007743A (es) * | 2002-02-13 | 2004-10-15 | Hoffmann La Roche | Nuevos derivados de piridina y quinolina. |
| CN100503607C (zh) * | 2003-06-02 | 2009-06-24 | 新疆华世丹药物研究有限责任公司 | 去氢骆驼蓬碱衍生物类化合物及其应用 |
| EP2120994B1 (de) * | 2007-01-08 | 2014-06-11 | The Trustees of the University of Pennsylvania | Verfahren und zusammensetzungen zur behandlung hypoglykämischer zustände |
| AU2008302751A1 (en) * | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| WO2009067233A1 (en) * | 2007-11-20 | 2009-05-28 | Millennium Pharmaceuticals, Inc. | Beta carbolines and uses thereof |
| CA3024358A1 (en) | 2015-05-22 | 2016-12-01 | The Bot Of The Leland Stanford Junior University | Treatment of post-bariatric hypoglycemia with exendin(9-39) |
| US10653753B2 (en) | 2016-03-04 | 2020-05-19 | Eiger Biopharmaceuticals, Inc. | Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives |
| JP2019535734A (ja) | 2016-11-21 | 2019-12-12 | アイガー・バイオファーマシューティカルズ・インコーポレイテッドＥｉｇｅｒ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | エキセンディン（９−３９）の緩衝製剤 |
| CN111362937B (zh) * | 2020-03-06 | 2021-06-22 | 贵州医科大学 | N-芳基-β-卡波林类衍生物及其用途 |
| IL300048A (en) * | 2020-07-23 | 2023-03-01 | Merck Patent Gmbh | Heterocyclic compounds with three rings, their preparation and use |
| CA3195925A1 (en) * | 2020-10-30 | 2022-05-05 | Robin Elaine DUNCAN | Modulation of glucagon-like peptide 1 and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0823909B1 (de) * | 1995-05-05 | 2002-09-11 | British Technology Group Inter-Corporate Licensing Limited | Neue heterozyklische chemie |
-
1999
- 1999-12-08 AT AT99960663T patent/ATE288268T1/de not_active IP Right Cessation
- 1999-12-08 JP JP2000586331A patent/JP2002531501A/ja active Pending
- 1999-12-08 CA CA002350887A patent/CA2350887A1/en not_active Abandoned
- 1999-12-08 KR KR1020017007173A patent/KR20010089563A/ko not_active Application Discontinuation
- 1999-12-08 DE DE69923587T patent/DE69923587T2/de not_active Expired - Fee Related
- 1999-12-08 ES ES99960663T patent/ES2233089T3/es not_active Expired - Lifetime
- 1999-12-08 BR BR9916965-7A patent/BR9916965A/pt not_active IP Right Cessation
- 1999-12-08 NZ NZ511698A patent/NZ511698A/en unknown
- 1999-12-08 EP EP99960663A patent/EP1137413B1/de not_active Expired - Lifetime
- 1999-12-08 US US09/831,572 patent/US6469021B1/en not_active Expired - Fee Related
- 1999-12-08 PT PT99960663T patent/PT1137413E/pt unknown
- 1999-12-08 AU AU17518/00A patent/AU758968B2/en not_active Ceased
- 1999-12-08 WO PCT/US1999/029065 patent/WO2000033839A1/en active IP Right Grant
-
2001
- 2001-05-21 ZA ZA200104128A patent/ZA200104128B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6469021B1 (en) | 2002-10-22 |
| EP1137413A2 (de) | 2001-10-04 |
| CA2350887A1 (en) | 2000-06-15 |
| AU1751800A (en) | 2000-06-26 |
| ATE288268T1 (de) | 2005-02-15 |
| PT1137413E (pt) | 2005-05-31 |
| AU758968B2 (en) | 2003-04-03 |
| EP1137413A4 (de) | 2002-06-26 |
| ES2233089T3 (es) | 2005-06-01 |
| NZ511698A (en) | 2003-09-26 |
| BR9916965A (pt) | 2001-11-06 |
| WO2000033839B1 (en) | 2000-09-28 |
| WO2000033839A1 (en) | 2000-06-15 |
| JP2002531501A (ja) | 2002-09-24 |
| DE69923587T2 (de) | 2005-06-23 |
| KR20010089563A (ko) | 2001-10-06 |
| EP1137413B1 (de) | 2005-02-02 |
| ZA200104128B (en) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE288268T1 (de) | Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden | |
| EP1590336A4 (de) | Substituierte pyrazole, zusammensetzungen,die solche verbindungen enthalten, und anwendungsverfahren | |
| ZA981627B (en) | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds. | |
| MX9500072A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
| YU19903A (sh) | Novi receptor nukleinskih kiselina i polipeptida | |
| EP1773330A4 (de) | Substituierte pyrazole, derartige verbindungen enthaltende zusammensetzungen und verfahren zu ihrer verwendung | |
| DE60005560D1 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
| YU22000A (sh) | Biciklični inhibitori kinaze | |
| MXPA03004779A (es) | Nuevas benzazepinas y derivados heterociclicos relacionados, utiles como antagonistas del receptor de orexina. | |
| ES2154167B1 (es) | Aminoderivados ciclicos antagonistas del receptor ccr-3. | |
| ES2000299A6 (es) | Procedimiento para la preparaciom de nuevos derivados de n-aralquil-piperinmetanol | |
| IL139956A0 (en) | Conformationally constrained backbone cyclized somatostatin analogs | |
| YU80902A (sh) | Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže | |
| ATE357917T1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
| EP1181555A4 (de) | Krebsbehandlung mit antagonisten des endothelinrezeptors | |
| GR950300029T1 (en) | Dna encoding a human serotonin receptor (5-ht4b)a nd uses thereof. | |
| MY127385A (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperlasia | |
| HK1026701A1 (en) | Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof | |
| HK1064683A1 (en) | Receptor of the edb fibronectin domains (II) | |
| BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
| EP0960937A4 (de) | Neues semaphorin-gen: semaphorin y | |
| AU5722499A (en) | G protein-coupled receptor agonists or antagonists | |
| NO20002408L (no) | 5-HT1F antagonister | |
| GB0011071D0 (en) | Organic compounds | |
| EP1346983A3 (de) | Phthalimido-arylpiperazine als alpha 1A Rezeptor Antagonisten nützlich zur Behandlung von gutartiger Prostatahyperplasie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |